S&P TSX Capped Composite...

US Dollar vs CAD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

AQST Aquestive Therapeutics Inc

2.73

-0.08 (-2.85%)

Jun 07 2024 - Closed

Delayed by 15 minutes

Form SC 13G - Statement of acquisition of beneficial ownership by individuals

null

Aquestive Therapeutics (NASDAQ:AQST)
Historical Stock Chart
From May 2024 to Jun 2024

Click Here for more Aquestive Therapeutics Charts.

Aquestive Therapeutics (NASDAQ:AQST)
Historical Stock Chart
From Jun 2023 to Jun 2024

Click Here for more Aquestive Therapeutics Charts.

Aquestive Therapeutics Inc News

Form 8-K - Current report
Friday 7 June 2024 (24 hours ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 6 June 2024 (2 days ago) • Edgar (US Regulatory)

Aquestive Therapeutics Announces Executive Appointments and Builds Commercial Capabilities
Monday 3 June 2024 (5 days ago) • GlobeNewswire Inc.

Aquestive Therapeutics to Present Anaphylm™ (epinephrine) Sublingual Film Pharmacokinetic and Pharmacodynamic Data At 2024 Eastern Allergy Conference
Tuesday 28 May 2024 (2 weeks ago) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Monday 13 May 2024 (4 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Monday 13 May 2024 (4 weeks ago) • Edgar (US Regulatory)

Aquestive Therapeutics to Participate in The Citizens JMP Life Sciences Conference
Thursday 9 May 2024 (1 month ago) • GlobeNewswire Inc.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Tuesday 7 May 2024 (1 month ago) • Edgar (US Regulatory)

Form 8-K - Current report
Tuesday 7 May 2024 (1 month ago) • Edgar (US Regulatory)

Aquestive Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
Tuesday 7 May 2024 (1 month ago) • GlobeNewswire Inc.

Aquestive Therapeutics Receives U.S. FDA Approval and Market Access for Libervant™ (diazepam) Buccal Film in Pediatric Patients Ages 2 to 5 and Provides Update on Anaphylm™ (epinephrine) Sublingual Film
Monday 29 April 2024 (1 month ago) • GlobeNewswire Inc.

Aquestive Therapeutics to Report First Quarter 2024 Financial Results and Recent Business Highlights on May 7 and Host Conference Call on May 8 at 8:00 a.m. ET
Thursday 25 April 2024 (1 month ago) • GlobeNewswire Inc.

More Aquestive Therapeutics Inc News Articles

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions